357 related articles for article (PubMed ID: 32832592)
1. CRISPR Technology for Breast Cancer: Diagnostics, Modeling, and Therapy.
Mintz RL; Gao MA; Lo K; Lao YH; Li M; Leong KW
Adv Biosyst; 2018 Nov; 2(11):. PubMed ID: 32832592
[TBL] [Abstract][Full Text] [Related]
2. Breast Cancer Transcriptional Regulatory Network Reprogramming by using the CRISPR/Cas9 System: An Oncogenetics Perspective.
Singh DD; Verma R; Tripathi SK; Sahu R; Trivedi P; Yadav DK
Curr Top Med Chem; 2021; 21(31):2800-2813. PubMed ID: 34477520
[TBL] [Abstract][Full Text] [Related]
3. Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/Cas Advancement in Molecular Diagnostics and Signal Readout Approaches.
Ahmed MZ; Badani P; Reddy R; Mishra G
J Mol Diagn; 2021 Nov; 23(11):1433-1442. PubMed ID: 34454111
[TBL] [Abstract][Full Text] [Related]
4. Applications of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) as a Genetic Scalpel for the Treatment of Cancer: A Translational Narrative Review.
Mondal R; Brahmbhatt N; Sandhu SK; Shah H; Vashi M; Gandhi SK; Patel P
Cureus; 2023 Dec; 15(12):e50031. PubMed ID: 38186450
[TBL] [Abstract][Full Text] [Related]
5. Application of the CRISPR/Cas9 System to Drug Resistance in Breast Cancer.
Chen Y; Zhang Y
Adv Sci (Weinh); 2018 Jun; 5(6):1700964. PubMed ID: 29938175
[TBL] [Abstract][Full Text] [Related]
6. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
[TBL] [Abstract][Full Text] [Related]
7. Application of CRISPR/Cas9 Technology in Cancer Treatment: A Future Direction.
Rabaan AA; AlSaihati H; Bukhamsin R; Bakhrebah MA; Nassar MS; Alsaleh AA; Alhashem YN; Bukhamseen AY; Al-Ruhimy K; Alotaibi M; Alsubki RA; Alahmed HE; Al-Abdulhadi S; Alhashem FA; Alqatari AA; Alsayyah A; Farahat RA; Abdulal RH; Al-Ahmed AH; Imran M; Mohapatra RK
Curr Oncol; 2023 Feb; 30(2):1954-1976. PubMed ID: 36826113
[TBL] [Abstract][Full Text] [Related]
8. CRISPR/Cas9 based genome editing for targeted transcriptional control in triple-negative breast cancer.
Deepak Singh D; Han I; Choi EH; Yadav DK
Comput Struct Biotechnol J; 2021; 19():2384-2397. PubMed ID: 34025931
[TBL] [Abstract][Full Text] [Related]
9. Applications of CRISPR-Cas9 for advancing precision medicine in oncology: from target discovery to disease modeling.
Ravichandran M; Maddalo D
Front Genet; 2023; 14():1273994. PubMed ID: 37908590
[TBL] [Abstract][Full Text] [Related]
10. The role of CRISPR-Cas in advancing precision periodontics.
Barbour A; Glogauer J; Grinfeld L; Ostadsharif Memar R; Fine N; Tenenbaum H; Glogauer M
J Periodontal Res; 2021 Jun; 56(3):454-461. PubMed ID: 33452819
[TBL] [Abstract][Full Text] [Related]
11. Repurposing CRISPR System for Transcriptional Activation.
Chen M; Qi LS
Adv Exp Med Biol; 2017; 983():147-157. PubMed ID: 28639197
[TBL] [Abstract][Full Text] [Related]
12. CRISPR/Cas: Advances, Limitations, and Applications for Precision Cancer Research.
Yang Y; Xu J; Ge S; Lai L
Front Med (Lausanne); 2021; 8():649896. PubMed ID: 33748164
[TBL] [Abstract][Full Text] [Related]
13. Innovative Strategies of Reprogramming Immune System Cells by Targeting CRISPR/Cas9-Based Genome-Editing Tools: A New Era of Cancer Management.
Allemailem KS; Alsahli MA; Almatroudi A; Alrumaihi F; Al Abdulmonem W; Moawad AA; Alwanian WM; Almansour NM; Rahmani AH; Khan AA
Int J Nanomedicine; 2023; 18():5531-5559. PubMed ID: 37795042
[TBL] [Abstract][Full Text] [Related]
14. Advancements in CRISPR/Cas9 technology-Focusing on cancer therapeutics and beyond.
Mirza Z; Karim S
Semin Cell Dev Biol; 2019 Dec; 96():13-21. PubMed ID: 31150758
[TBL] [Abstract][Full Text] [Related]
15. Clustered Regularly Interspaced Short Palindromic Repeats and Clustered Regularly Interspaced Short Palindromic Repeats-Associated Protein 9 System: Factors Affecting Precision Gene Editing Efficiency and Optimization Strategies.
Li J; Tang C; Liang G; Tian H; Lai G; Wu Y; Liu S; Zhang W; Liu S; Shao H
Hum Gene Ther; 2023 Dec; 34(23-24):1190-1203. PubMed ID: 37642232
[TBL] [Abstract][Full Text] [Related]
16. The application of CRISPR-Cas9 genome editing tool in cancer immunotherapy.
Wu HY; Cao CY
Brief Funct Genomics; 2019 Mar; 18(2):129-132. PubMed ID: 29579146
[TBL] [Abstract][Full Text] [Related]
17. CRISPR/Cas9 gene-editing strategies in cardiovascular cells.
Vermersch E; Jouve C; Hulot JS
Cardiovasc Res; 2020 Apr; 116(5):894-907. PubMed ID: 31584620
[TBL] [Abstract][Full Text] [Related]
18. Harnessing the Potential of CRISPR/Cas in Atherosclerosis: Disease Modeling and Therapeutic Applications.
Siew WS; Tang YQ; Kong CK; Goh BH; Zacchigna S; Dua K; Chellappan DK; Duangjai A; Saokaew S; Phisalprapa P; Yap WH
Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445123
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9 Technology in Translational Biomedicine.
Leonova EI; Gainetdinov RR
Cell Physiol Biochem; 2020 Apr; 54(3):354-370. PubMed ID: 32298553
[TBL] [Abstract][Full Text] [Related]
20. CRISPR/Cas9: the Jedi against the dark empire of diseases.
Khan S; Mahmood MS; Rahman SU; Zafar H; Habibullah S; Khan Z; Ahmad A
J Biomed Sci; 2018 Mar; 25(1):29. PubMed ID: 29592810
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
